Iqvia Holdings Inc (NYSE:IQV) Receives $166.46 Average Target Price from Analysts

Share on StockTwits

Shares of Iqvia Holdings Inc (NYSE:IQV) have been assigned a consensus rating of “Buy” from the twenty brokerages that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, fifteen have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $166.46.

IQV has been the topic of a number of research reports. ValuEngine cut shares of Iqvia from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Wolfe Research upgraded shares of Iqvia from a “peer perform” rating to an “outperform” rating in a report on Thursday, November 14th.

Shares of NYSE:IQV opened at $143.84 on Monday. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 1.85. The firm has a market capitalization of $28.41 billion, a PE ratio of 28.09, a P/E/G ratio of 1.79 and a beta of 0.87. Iqvia has a twelve month low of $104.90 and a twelve month high of $164.13. The company has a 50-day moving average price of $144.73 and a two-hundred day moving average price of $149.71.

Iqvia (NYSE:IQV) last issued its earnings results on Wednesday, October 30th. The medical research company reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.03. Iqvia had a net margin of 2.24% and a return on equity of 16.95%. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.76 billion. During the same quarter last year, the business earned $1.42 earnings per share. The company’s quarterly revenue was up 6.7% on a year-over-year basis. Analysts anticipate that Iqvia will post 5.9 earnings per share for the current fiscal year.

A number of institutional investors have recently made changes to their positions in the stock. Creative Planning grew its position in shares of Iqvia by 4.9% during the second quarter. Creative Planning now owns 3,217 shares of the medical research company’s stock worth $518,000 after buying an additional 149 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. lifted its stake in Iqvia by 30.3% during the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 56,575 shares of the medical research company’s stock worth $9,103,000 after purchasing an additional 13,160 shares during the last quarter. Janney Montgomery Scott LLC lifted its stake in Iqvia by 2.3% during the second quarter. Janney Montgomery Scott LLC now owns 32,540 shares of the medical research company’s stock worth $5,236,000 after purchasing an additional 729 shares during the last quarter. Berman Capital Advisors LLC lifted its stake in Iqvia by 34.4% during the second quarter. Berman Capital Advisors LLC now owns 469 shares of the medical research company’s stock worth $75,000 after purchasing an additional 120 shares during the last quarter. Finally, Aviva PLC lifted its stake in Iqvia by 2.6% during the second quarter. Aviva PLC now owns 65,192 shares of the medical research company’s stock worth $10,489,000 after purchasing an additional 1,624 shares during the last quarter. Institutional investors own 89.89% of the company’s stock.

About Iqvia

IQVIA Holdings Inc provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Recommended Story: Range Trading

Analyst Recommendations for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bowling Portfolio Management LLC Has $822,000 Stake in Mastercard Inc
Bowling Portfolio Management LLC Has $822,000 Stake in Mastercard Inc
Chemung Financial Corp.  Shares Sold by Bowling Portfolio Management LLC
Chemung Financial Corp. Shares Sold by Bowling Portfolio Management LLC
Cisco Systems, Inc.  Shares Sold by Commerzbank Aktiengesellschaft FI
Cisco Systems, Inc. Shares Sold by Commerzbank Aktiengesellschaft FI
Bowling Portfolio Management LLC Has $810,000 Stake in Kennedy-Wilson Holdings Inc
Bowling Portfolio Management LLC Has $810,000 Stake in Kennedy-Wilson Holdings Inc
State of Alaska Department of Revenue Sells 1,055 Shares of Ferro Co.
State of Alaska Department of Revenue Sells 1,055 Shares of Ferro Co.
Central Garden & Pet Co  Shares Sold by State of Alaska Department of Revenue
Central Garden & Pet Co Shares Sold by State of Alaska Department of Revenue


© 2006-2020 Ticker Report